$104.60
0.41%
NYSE, Oct 02, 04:12 pm EDT. Closed.
ISIN
US0126531013
Symbol
ALB
Sector
Industry

Albemarle Stock price

$104.59
-33.16 24.07% 1M
-73.50 41.27% 6M
-36.85 26.05% YTD
+16.98 19.38% 1Y
-57.82 35.60% 3Y
-110.62 51.40% 5Y
+19.76 23.29% 10Y
+77.32 283.54% 20Y
NYSE, Closing price Fri, Oct 02 2026
-0.44 0.42%
ISIN
US0126531013
Symbol
ALB
Sector
Industry

AI Insights on Albemarle Insights AI Insights on Albemarle

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Is Albemarle a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.

Key metrics

Basic
Market capitalization
$12.3b
Enterprise Value
$12.6b
Net debt
$245.1m
Cash
$1.6b
Shares outstanding
118.0m
Valuation
P/E
249.0
P/S | estimate
2.1 | 2.0
EV/Sales | estimate
2.1 | 2.0
EV/FCF | ex SBC
9.4 | 9.6
P/B
1.2
Dividends
DPS
$1.62
Yield 1Y | 5Y
1.6% | 1.0%
Growth 1Y | 5Y
0.6% | 1.0%
Payout 1Y | 3Y
-28.1% | -134.2%
Increased
25 Years
Financials
Revenue | estimate
$5.9b | $6.2b
EBITDA
$1.5b
EBIT
$835.3m
Net Income
$57.4m
Free Cash Flow | ex SBC
$1.3b | $1.3b
Growth
Revenue | estimate
18.3% | 20.0%
EBITDA
246.5%
EBIT
461.8%
Net Income
105.2%
Free Cash Flow
838.8%
Margin
Gross
23.9%
EBITDA
25.0%
EBIT
14.1%
Net
1.0%
Free Cash Flow | ex SBC
22.7% | 22.1%
Financial Health
Equity Ratio
58.2%
Return on Equity
-7.1%
ROCE
6.0%
ROIC
-2.7%
Debt/Equity
0.2
Share-Based Compensation & Dilution
SBC | % of Revenue
$37.9m | 0.6%
SBC as % of FCF
2.8%
SBC Growth 1Y
12.1%
Share Count Growth 1Y
0.3%
Shareholder Yield
1.3%
More
EPS
$0.4
FCF per Share
$11.4
Short interest
0.0%
Employees
8k
Rev per Employee
$660.0k

Albemarle Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a Albemarle forecast:

18x Buy
67%
9x Hold
33%

Analyst Opinions

27 Analysts have issued a Albemarle forecast:

Buy
67%
Hold
33%

Albemarle Events

Past Events
AUG
6
Q2 2026 Earnings Call
about 2 months ago
MAY
7
Q1 2026 Earnings Call
5 months ago
FEB
12
Q4 2025 Earnings Call
8 months ago
NOV
6
Q3 2025 Earnings Call
11 months ago

Financial data from Albemarle

Jun '26
+/-
%
5,908 5,908
18% 18%
100%
- Direct Costs 4,496 4,496
2% 2%
76%
1,412 1,412
264% 264%
24%
- Selling and Administrative Expenses 539 539
2% 2%
9%
- Research and Development Expense 38 38
45% 45%
1%
1,477 1,477
247% 247%
25%
- Depreciation and Amortization 642 642
2% 2%
11%
EBIT (Operating Income) EBIT 835 835
462% 462%
14%
Net Profit 57 57
105% 105%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Albemarle directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Albemarle Stock News

Neutral
Market Watch
●
4 days ago
September has reminded investors that the S&P 500 is heavily weighted at the top. The becnhmark index has risen slightly, but 75% of its component stocks were down for the month.
Neutral
Reuters
●
about one month ago
Albemarle said ‌on Thursday it has appointed BHP executive ​Ragnar Udd as ​its CEO, tapping an ⁠industry veteran to ​lead the lithium producer.
Neutral
PRNewsWire
●
about one month ago
Ragnar Udd Appointed President and CEO, Effective February 1, 2027 Kent Masters to Serve as Executive Chairman CHARLOTTE, N.C., Sept. 3, 2026 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity and health, today announced that Ragnar "Rag" Udd has been appointed President and Chief Executive Officer, effective Feb...
More Albemarle News

Company Profile

Albemarle Corp. is a specialty company, which engages in developing, manufacturing, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment engages in developing and manufacture of basic lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties and reagents. The Bromine Specialties segment consists of bromine and bromine-based business includes products used in fire safety solutions and other specialty chemicals applications. The Catalysts segment contain two product lines: clean fuels technologies, which is primarily composed of hydro processing catalysts, and heavy oil upgrading that comprises of fluidized catalytic cracking catalysts and additives. The company was founded in 1993 and is headquartered in Charlotte, NC.

Head office United States
CEO Mr. Masters
Employees 7,800
Founded 1993
Website www.albemarle.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today